Hypnotics and Sedatives
Research News and Information

Saturday, November 21, 2009

Low-dose oral midazolam reduces fear and distress during needle procedures in children with cancer.

13 Dec 2009 BACKGROUND: Children with cancer often mention needle procedures as the most frightening, distressing, and sometimes painful aspect of the disease and treatment. The aim was to investigate whether children experience less fear, distress, and/or pain ... Read more...

Hemolytic anemia after zopiclone overdose.

30 Oct 2009 INTRODUCTION: Zopiclone is associated with methemoglobinemia. We report a case of zopiclone overdose manifested with another hematological complication, hemolysis. CASE: A 46-year-old woman overdosed with 50-100 tablets of 7.5 mg zopiclone. ... Read more...

Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine COmpared to Morphine-DEXCOM Study).

30 Oct 2009 BACKGROUND: Commonly used sedatives/analgesics can increase the risk of postoperative complications, including delirium. This double-blinded study assessed the neurobehavioral, hemodynamic, and sedative characteristics of dexmedetomidine compared ... Read more...

Latest indexed articles for 'Hypnotics and Sedatives'

These are the very latest articles for this heading:

• Low-dose oral midazolam reduces fear and distress during needle procedures in children with cancer. 13 Dec 2009
• Hemolytic anemia after zopiclone overdose. 30 Oct 2009
• Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine COmpared to Morphine-DEXCOM Study). 30 Oct 2009
• "Above all, do no harm": hippocrates. 30 Oct 2009
• Perineural dexmedetomidine added to ropivacaine causes a dose-dependent increase in the duration of thermal antinociception in sciatic nerve block in rat. 30 Oct 2009
• When drugs disappear from the patient: elimination of intravenous medication by hemodiafiltration. 30 Oct 2009
• Comparison between dexmedetomidine and remifentanil for intraoperative controlled hypotension. 30 Oct 2009
• Pain management and sedation for children in the emergency department. 28 Oct 2009
• Lost in transmission--FDA drug information that never reaches clinicians. 19 Oct 2009
• [Delirium in the critically ill] 17 Oct 2009
• Propofol infusion syndrome with arrhythmia, myocardial fat accumulation and cardiac failure. 13 Oct 2009
• Analgesia accompanying food consumption requires ingestion of hedonic foods. 12 Oct 2009
• Schedule of controlled substances; placement of fospropofol into schedule IV. Final rule. 4 Oct 2009
• [Benzodiazepine reduction does not imply an increased consumption of antidepressants. A survey of two medical practices] 3 Oct 2009
• Zolpidem dependence in a geriatric patient: a case report. 29 Sep 2009
• Last-resort options for palliative sedation. 13 Sep 2009
• [Nurse administered propofol sedation in connection with endoscopy] 12 Sep 2009
• Cognitive behavioral therapy alone and with medication for persistent insomnia. 7 Sep 2009
• Cognitive behavioral therapy alone and with medication for persistent insomnia. 7 Sep 2009
• Effects of propofol or etomidate on QT interval during electroconvulsive therapy. 30 Aug 2009

See a longer list of these articles.

Technical information about 'Hypnotics and Sedatives'

Definition: Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.

Registry Number: 0

Descriptor UI: D006993

Alternative terms: Hypnotics and Sedatives; Sedatives and Hypnotics; Sedatives; Hypnotics;

Related Mesh Headings: Histamine H1 Antagonists; Tranquilizing Agents;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.696.277.350; D27.505.696.410; D27.505.954.427.210.350; D27.505.954.427.325;

Technical Notes: CNS depressants; GEN: prefer specifics; DF: HYPNOTICS